{"id":"NCT03983980","sponsor":"Organon and Co","briefTitle":"Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)","officialTitle":"A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Plaque Psoriasis in Adults","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-06-06","primaryCompletion":"2020-05-13","completion":"2020-05-29","firstPosted":"2019-06-12","resultsPosted":"2022-10-13","lastUpdate":"2025-06-12"},"enrollment":515,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Plaque Psoriasis"],"interventions":[{"type":"DRUG","name":"Tapinarof","otherNames":["DMVT-505"]},{"type":"DRUG","name":"Vehicle Cream","otherNames":[]}],"arms":[{"label":"Tapinarof (DMVT-505) Cream Group","type":"EXPERIMENTAL"},{"label":"Vehicle Cream Group","type":"PLACEBO_COMPARATOR"}],"summary":"This is a randomized double-blind vehicle-controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% once daily for the treatment of plaque psoriasis in adults. Approximately 500 adult subjects with plaque psoriasis will be randomized 2:1 to receive either tapinarof cream, 1% or matching vehicle cream once daily for 12 weeks.","primaryOutcome":{"measure":"Percent of Subjects Who Achieve a Physician Global Assessment (PGA) Score of Clear (0) or Almost Clear (1) With a Minimum 2-grade Improvement From Baseline at Week 12. Analyses Were Done Using Multiple Imputation","timeFrame":"Baseline to Week 12","effectByArm":[{"arm":"Tapinarof (DMVT-505) Cream Group","deltaMin":40.2,"sd":2.82},{"arm":"Vehicle Cream Group","deltaMin":6.3,"sd":1.99}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":21},"locations":{"siteCount":50,"countries":["United States","Canada"]},"refs":{"pmids":["34879448","40600584","38123875","37697121"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":343},"commonTop":["Folliculitis","Upper respiratory tract infection","Nasopharyngitis","Dermatitis contact","Headache"]}}